Irvine, CA, United States of America

Biolase, Inc.


USPTO Granted Patents = 56

% Expired Patents = 19.6



Trademarks = 20

Forward Citations = 1,195

Loading Chart...
Loading Chart...

29 inventors (with patents filed for the assignee):

goldMedal Dmitri Boutoussov (40 out of 72 patents)

silverMedal Marcia Angela Van Valen (11 out of 21 patents)

bronzeMedal Richard Jackson (10 out of 11 patents)

4.  Jeffrey W Jones (10 out of 38 patents)

5.  Douglas Patton (9 out of 13 patents)

6.  Ioana M Rizoiu (7 out of 49 patents)

7.  Vladimir S Netchitailo (5 out of 5 patents)

8.  Christopher J Walinski (4 out of 4 patents)

9.  Amado Carino (4 out of 4 patents)

10.  William E Brown, Jr (4 out of 6 patents)

11.  Doug Patton (3 out of 3 patents)

12.  Channing Shattuck (3 out of 11 patents)

13.  Alina Sivriver (3 out of 4 patents)

14.  David Tuck (3 out of 3 patents)

15.  Glenn Empey (3 out of 3 patents)


Core Competencies:
Dental Laser
Graphical User Interface
Optical Fibers
Laser Treatment
Dental System
Multiple Beam Laser
Surgical Laser
Eyelid Treatment
Handpiece Assembly
Electromagnetic Energy
Teeth Whitening
Low-Level Light Therapy

56 patents:

Biolase, Inc. is a leading innovator in dental laser technology, headquartered in Irvine, California. The company specializes in the development and manufacturing of advanced dental systems that utilize laser treatment for a variety of applications, including surgical procedures and eyelid treatments. Biolase's core technologies encompass multiple beam lasers, optical fibers, and user-friendly graphical interfaces, enhancing precision and efficiency in dental practices. Their commitment to improving patient outcomes positions them at the forefront of dental technology.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Biolase, Inc.
56 Patents

#61 in Irvine, CA

#1,490 in California

#6,346 in US

#12,732 in the World

Irvine, CA (US)
Irvine, CA, United States of America
Forward Citations = 1,195

29 inventors:

Please report any incorrect information to [email protected]
Loading…